25 patents currently held
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1 more record may belong here and awaits a decision; it is not counted.
The next term ends in Feb 2033. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Feb 2033
Next term end
7
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jun 2033 · High confidence
Also notable
Ends Feb 2033 · High confidence
Also notable
Ends Oct 2033 · Medium confidence
System and Method for Processing and Detecting Nucleic Acids
US 9,050,594
The most cited patent in this portfolio, cited by 79 later US patents, top 5% of utility patents granted in 2015 in our data. Protection runs to 2033.
Microfluidic Cartridge for Processing and Detecting Nucleic Acids
US 9,101,930
Cited by 55 later US patents, top 10% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2033. A terminal disclaimer caps this term to an earlier patent's.
Method and Materials for Isolation of Nucleic Acid Materials
US 9,382,532
Cited by 29 later US patents, top 25% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2033.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Nov 16 to 23, 2026 · next Nov 16
- 1 fee due Dec 9, 2026The maintenance fee for System and Method for Processing and Detecting Nucleic Acids (US 9,050,594) comes due Dec 9, 2026. Unpaid by Jun 9, 2027, it lapses early.
- 1 fee due Jan 25, 2027The maintenance fee for Pin-Based Valve Actuation System for Processing Biological Samples (US 11,708,597) comes due Jan 25, 2027. Unpaid by Jul 26, 2027, it lapses early.
- 2 fees due Feb 8 to 11, 2027 · next Feb 8
- 1 fee due Aug 11, 2027The maintenance fee for Microfluidic Cartridge for Processing and Detecting Nucleic Acids (US 10,557,132) comes due Aug 11, 2027. Unpaid by Feb 11, 2028, it lapses early.
- 1 fee due Sep 19, 2027The maintenance fee for System and Method for Processing and Detecting Nucleic Acids (US 11,931,740) comes due Sep 19, 2027. Unpaid by Mar 20, 2028, it lapses early.
- 1 fee due Oct 28, 2027The maintenance fee for Method and Materials for Isolation of Nucleic Acid Materials (US 10,633,647) comes due Oct 28, 2027. Unpaid by Apr 28, 2028, it lapses early.
Recent changes
- 1 term has ended since Aug 17, 2026
What they patent
The 5 largest of its 7 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| System and Method for Processing and Detecting Nucleic Acids | 12 in force | to Dec 2033 |
| Thermocycling System, Composition, and Microfabrication Method | 3 in force | to Jan 2035 |
| Method and Materials for Isolation of Nucleic Acid Materials | 3 in force | to Oct 2033 |
| Microfluidic Cartridge for Processing and Detecting Nucleic Acids | 3 in force | to Feb 2033 |
| Thermocycling System and Manufacturing Method | 2 in force | to Jan 2035 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,101,930 | Microfluidic Cartridge for Processing and Detecting Nucleic Acids In force · High confidence | In force | High confidence | |
| US 9,403,165 | Microfluidic Cartridge for Processing and Detecting Nucleic Acids In force · High confidence | In force | High confidence | |
| US 9,433,940 | Microfluidic Cartridge for Processing and Detecting Nucleic Acids In force · High confidence | In force | High confidence | |
| US 9,441,219 | System and Method for Processing and Detecting Nucleic Acids In force · High confidence | In force | High confidence | |
| US 9,452,430 | Microfluidic Cartridge for Processing and Detecting Nucleic Acids In force · High confidence | In force | High confidence | |
| US 9,604,213 | System and Method for Processing and Detecting Nucleic Acids In force · High confidence | In force | High confidence | |
| US 10,010,888 | System and Method for Processing and Detecting Nucleic Acids In force · High confidence | In force | High confidence | |
| US 10,557,132 | Microfluidic Cartridge for Processing and Detecting Nucleic Acids In force · High confidence | In force | High confidence | |
| US 11,485,968 | Microfluidic Cartridge for Processing and Detecting Nucleic Acids In force · Low confidence | In force | Low confidence | |
| US 11,648,561 | System and Method for Processing and Detecting Nucleic Acids In force · High confidence | In force | High confidence |
Also on record, not counted in the 25: 5 patents ended · 11 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.